News Conference News ACC 2023 AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup L.A. McKeown March 09, 2023
News Daily News New Data Support Tighter Air Pollution Standards to Reduce CV Events L.A. McKeown February 27, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Daily News Prehospital Troponin Testing With EMS Input Could Save a Lot of Money Michael O'Riordan February 07, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Daily News Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees Michael O'Riordan January 05, 2023
News Daily News Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance L.A. McKeown December 20, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News A Simple Nudge Moves the Needle on Statin Prescribing Michael O'Riordan December 02, 2022
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Daily News How Lp(a) Levels Compare With LDL-C in FH: Some Surprises Michael O'Riordan November 17, 2022
News Conference News AHA 2022 High-Sensitivity Troponin Testing on the Rise in the US but Still Limited Michael O'Riordan November 04, 2022
News Daily News STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden Caitlin E. Cox October 31, 2022
News Conference News EACTS 2022 FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry Michael O'Riordan October 07, 2022
News Daily News Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks Michael O'Riordan October 07, 2022
News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022